V-9302
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 563923

CAS#: 1855871-76-9

Description: V-9302 is a competitive antagonist of transmembrane glutamine flux (ASCT2 inhibitor), selectively and potently targeting the amino acid transporter ASCT2.


Price and Availability

Size
Price

5mg
USD 150
50mg
USD 750
500mg
USD 2950
Size
Price

10mg
USD 250
100mg
USD 1250
1g
USD 3850
Size
Price

25mg
USD 450
200mg
USD 1950
2g
USD 6950

V-9302, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 563923
Name: V-9302
CAS#: 1855871-76-9
Chemical Formula: C34H38N2O4
Exact Mass: 538.2832
Molecular Weight: 538.69
Elemental Analysis: C, 75.81; H, 7.11; N, 5.20; O, 11.88


Synonym: V-9302; V9302; V 9302

IUPAC/Chemical Name: (S)-2-Amino-4-(bis(2-((3-methylbenzyl)oxy)benzyl)amino)butanoic acid

InChi Key: YGKNVAAMULVFNN-HKBQPEDESA-N

InChi Code: InChI=1S/C34H38N2O4/c1-25-9-7-11-27(19-25)23-39-32-15-5-3-13-29(32)21-36(18-17-31(35)34(37)38)22-30-14-4-6-16-33(30)40-24-28-12-8-10-26(2)20-28/h3-16,19-20,31H,17-18,21-24,35H2,1-2H3,(H,37,38)/t31-/m0/s1

SMILES Code: O=C(O)[C@@H](N)CCN(CC1=CC=CC=C1OCC2=CC=CC(C)=C2)CC3=CC=CC=C3OCC4=CC=CC(C)=C4


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>3 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:
2934.99.90.01


References

1: Schulte ML, Fu A, Zhao P, Li J, Geng L, Smith ST, Kondo J, Coffey RJ, Johnson MO, Rathmell JC, Sharick JT, Skala MC, Smith JA, Berlin J, Washington MK, Nickels ML, Manning HC. Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models. Nat Med. 2018 Feb;24(2):194-202. doi: 10.1038/nm.4464. Epub 2018 Jan 15. PubMed PMID: 29334372; PubMed Central PMCID: PMC5803339.